10.1111/j.1559-4572.2009.00054.x 47 KissenR.RossiterJ
This review evaluates the antihypertensive potential of sodium-glucose cotransporter-2 inhibitors (SGLT2-i) and glucagon-like peptide-1 receptor agonists (GLP-1RA), particularly in patients with comorbid diabetes, HF, CKD or resistant hypertension
Discussion Our results show that glutamine is a potent stimulus of GLP-1 secretion from GLUTag cells
Recent studies have demonstrated that the GLP-1 agonist, liraglutide, exerts an antipsychotic effect in a mouse model of psychosis (Lietzau et al., 2020)
Johansen, Jette Nowak b, Christian Skjrbk, et al (1999) Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats Growth Hormone & IGF Research, Volume 9, Issue 2, May 1999, Pages 106-113 (4) E Szentirmai, I Hajdu, F Obal Jr, and J M Krueger (2006) Ghrelin-induced sleep responses in ad libitum fed and food-restricted rats Brain Research Bulletin, 2006 May 30, Volume 69 (Issue 5), Pages 452-60